Adenosine Monophosphate Activated Kinase (AMPK) the Breakthrough Target for Metabolic Syndrome

Journal Title: Scholars Journal of Applied Medical Sciences - Year 2014, Vol 2, Issue 3

Abstract

Abstract: Metabolic syndrome is the challenging condition in current scenario in developing countries. To overcome it, the best target identification is the most challenging task. The enzyme Adenosine Monophosphate Activated Protein Kinase (AMPK) could be one of the targets to battle against such intricate conditions. The Adenosine Monophosphate Activated Protein Kinase (AMPK), a heterotrimeric serine/threonine protein kinase. Activated AMPK switches cells from an anabolic to a catabolic state, shutting down the ATP-consuming synthetic pathways and restoring energy balance, regulates key metabolic enzymes to reduce the activity of ATP-utilizing biosynthetic pathways and increase the activity of ATP-generating pathway. The fuel-sensing enzyme 5'-AMP-activated protein kinase (AMPK) has a major role in the regulation of cellular lipid and protein metabolism in response to stimuli such as exercise, changes in fuel availability and the adipocyte-derived hormones leptin and adiponectin. Abnormalities in cellular lipid metabolism are involved in the pathogenesis of the metabolic syndrome, possibly because of dysregulation of AMPK and Malonyl-CoA.It is now recognized that pharmacological activation of AMPK improves blood glucose homeostasis, lipid profile and blood pressure in insulin-resistant conditions. Indeed, AMPK activation mimics the beneficial effects of physical activity or those of calorie restriction by acting on multiple cellular targets. In addition, AMPK is one of the probable targets of major antidiabetic drugs including, the biguanides (metformin) and thiazolidinedione, as well as of insulin sensitizing adipokines (e.g., adiponectin). Taken together, such findings highlight the logic underlying the concept of targeting the AMPK pathway for the treatment of metabolic syndrome. Keywords: Metabolic syndrome, AMPK, ACC-2, HMGCo-A Reductase, CPT.

Authors and Affiliations

Abhishek B. Jha

Keywords

Related Articles

How Water Sanitation Affect Water Born Diseases

Water borne diseases are caused by pathogenic microorganism that most commonly are transmitted in contaminated fresh water. Various forms of waterborne diarrheal diseases (Hepatitis A and Diarrhea) probably are the most...

Facial Nerve Palsy and Management: Our Experience

Abstract: The Facial nerve is the most common cranial nerve to be paralysed due to the fact that it has a long intracranial route, related to the ear and parotid gland and thus susceptible to injuries and infections. Thi...

Epitheloid Hemangioendothelioma of Ileum Presenting with Intussusception: Report of a Rare Disease

Intestinal obstruction is frequently encountered in emergency and intussusception is one of the etiology. The cause of obstruction differs in adult from pediatric age groups, where intussusception is one of the...

Factors affecting Early Age Marriage in Morang District of Nepal

Abstract: Child marriage in Nepal is considered a major barrier to the nation's social and economic development, as well as a major women's health concern. The objective of the study was to find out the factors associate...

Study of Insulin Resistance by Homeostatic Model Assessment (Homa) in Type 2 Diabetes Mellitus Patients and Its Correlation with Diabetic Nephropathy

Abstract: Many studies showed that Insulin resistance is present in chronic renal failure and evidences suggest that Insulin resistance can also occur in early stages of renal disease. In Indian Scenario there is paucity...

Download PDF file
  • EP ID EP374308
  • DOI -
  • Views 57
  • Downloads 0

How To Cite

Abhishek B. Jha (2014). Adenosine Monophosphate Activated Kinase (AMPK) the Breakthrough Target for Metabolic Syndrome. Scholars Journal of Applied Medical Sciences, 2(3), 911-916. https://europub.co.uk/articles/-A-374308